Psychometric properties of the Slovenian versions of the diabetes empowerment scale, long and short form, among the slovenian adults with type 2 diabetes
Primary Care Diabetes · 2024
DOI: 10.1016/j.pcd.2024.10.002 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Primary Care Diabetes, 2024. Verfasst von Tina Virtič Potočnik und 6 weiteren Autor:innen. Beteiligte Einrichtung: Community Health Centre Ljubljana, Primary Healthcare Research and Development Institute, Metelkova 9, Ljubljana 1000, Slovenia; University of Maribo…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Psychometrics, Health Knowledge, Attitudes, Practice. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020, European Commission, Horizon 2020 Framework Programme.
Themen: Diabetes mellitus
Abstract (Originalsprache)
AIMS: To determine the psychometric properties of the Slovenian versions of the Diabetes Empowerment Scale (DES), both the long form (S-DES-LF) and the short form (S-DES-SF). METHODS: Between April and September 2023, we recruited adults with type 2 diabetes (T2D) using convenient sampling in five primary health centres. We examined internal consistency, test-retest reliability, criterion validity, and discriminant validity. Confirmatory factor analysis (CFA) evaluated the fit of the one-and three-factor models for S-DES-SF and S-DES-LF, respectively. RESULTS: The results of 288 individuals, with a mean age of 67 ± 9.2 years, including 132 men and 156 women, showed excellent internal consistency and strong test-retest reliability for both the S-DES-LF (Cronbach's α=0.90; ICC=0.95) and S-DES-SF (α=0.91; ICC=0.92). Criterion validity of the S-DES-LF was confirmed through known-groups validity, with higher education (p=0.016) and absence of comorbid hypertension (p=0.034) associated with greater empowerment. Discriminant validity was demonstrated by the lack of significant correlations between the S-DES-LF and S-DES-SF scores with age or gender. CFA confirmed a good fit for the S-DES-SF's one-factor model but not for S-DES-LF three-factor model. CONCLUSIONS: S-DES-LF and S-DES-SF are valid and reliable tools for assessing diabetes empowerment in Slovenian people with T2D. Future research should further explore the convergent validity of scales.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Community Health Centre Ljubljana, Primary Healthcare Research and Development Institute, Metelkova 9, Ljubljana 1000, Slovenia; University of Maribor, Faculty of Medicine, Department of Family Medicine, Taborska 8, Mar…
- Community Health Centre Ljubljana, Primary Healthcare Research and Development Institute, Metelkova 9, Ljubljana 1000, Slovenia; University of Ljubljana, Faculty of Medicine, Department of Family Medicine, Poljanski nas…
- Community Health Centre Ljubljana, Primary Healthcare Research and Development Institute, Metelkova 9, Ljubljana 1000, Slovenia.
Förderung
- Horizon 2020
- European Commission
- Horizon 2020 Framework Programme
Zitieren
APA
Virtič Potočnik, T., Miroševič, Š., Mihevc, M., Zavrnik, Č., Lukančič, M. M., Poplas Susič, T., & Klemenc-Ketiš, Z. (2024). Psychometric properties of the Slovenian versions of the diabetes empowerment scale, long and short form, among the slovenian adults with type 2 diabetes. Primary Care Diabetes. https://doi.org/10.1016/j.pcd.2024.10.002
Vancouver
Virtič Potočnik T, Miroševič Š, Mihevc M, Zavrnik Č, Lukančič MM, Poplas Susič T, et al. Psychometric properties of the Slovenian versions of the diabetes empowerment scale, long and short form, among the slovenian adults with type 2 diabetes. Primary Care Diabetes. 2024. doi:10.1016/j.pcd.2024.10.002
BibTeX
@article{VirtiPotonik2024,
author = {Virtič Potočnik, Tina and Miroševič, Špela and Mihevc, Matic and Zavrnik, Črt and Lukančič, Majda Mori and Poplas Susič, Tonka and Klemenc-Ketiš, Zalika},
title = {Psychometric properties of the Slovenian versions of the diabetes empowerment scale, long and short form, among the slovenian adults with type 2 diabetes},
journal = {Primary Care Diabetes},
year = {2024},
doi = {10.1016/j.pcd.2024.10.002}
}
EUVIMED